✦ LIBER ✦

Statins, bone, and neurofibromatosis type 1

✍ Scribed by Bruce R Korf

Book ID: 115021951
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 200 KB
Volume: 6
Category: Article
ISSN: 1741-7015
DOI: 10.1186/1741-7015-6-22

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statin Therapy and Cognitive Deficits As

Statin Therapy and Cognitive Deficits Associated With Neurofibromatosis Type 1

✍ Jansen, Jacobus F. A. 📂 Article 📅 2008 🏛 American Medical Association 🌐 English ⚖ 53 KB

Modelling bone healing deficiencies in T

Modelling bone healing deficiencies in Type 1 neurofibromatosis

✍ D.G. Little; J. El-Hoss; L. Peacock; K. Mikulec; I. Alexander; A. Schindeler 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Neurofibromatosis Type 1

✍ North, Kathryn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Neurofibromatosis 1 (NF1) is an autosomal dominant neurocutaneous disorder with an incidence of approximately 1 in 4000. Cognitive deficits and academic learning difficulties are the most common neurological 'complication' of NF1 in childhood and can be responsible for significant lifetime morbidity

Neurofibromatosis type 1

✍ Luis F Parada 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Neurofibromatosis type 1

✍ Kevin P. Boyd; Bruce R. Korf; Amy Theos 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Von Recklinghausen's neurofibromatosis:

Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1

✍ RM Reynolds; GGP Browning; I Nawroz; IW Campbell 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 277 KB